Home » Taxus Drug-Eluting Stent System Receives CE Marking for Use in Diabetic Patients
Taxus Drug-Eluting Stent System Receives CE Marking for Use in Diabetic Patients
Boston Scientific Corporation announced that its Taxus Liberte paclitaxel-eluting coronary stent system has received European CE Mark approval for use in patients with diabetes.
Boston Scientific
Boston Scientific
Upcoming Events
-
07May
-
14May
-
30May